GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.
Invitrogen has created three new business divisions in a move to
strengthen its position in the growing biotechnology industry and
drive growth through improving links between its product
development cycle and customer base.
Life sciences investment group Abingworth Management has announced
the initial Abingworth BioEquities Fund (ABE) has raised $53
million (€44 million) to invest across the life sciences field
including human therapeutics.
Emerson Process Management has stepped up its efforts to sell its
engineering, process control and digital automation technologies
into the life sciences sector with the launch of a new programme,
called OpX, at the Interphex exhibition...
France's drug industry has started filling in the detail of its
strategic plan to boost the standing of the biotechnology sector,
first unveiled at the end of last month. At the heart of the plans
is a quadrupling of the production...
Purification and filtration systems manufacturer Pall has reported
flat fiscal fourth-quarter earnings that missed analysts'
expectations, although group sales grew by 7 per cent to $504.5
The enlargement of the European Union to include 10 new countries
has raised fears about the impact this could have on issues such as
parallel imports and intellectual property protection, but it could
reinvigorate the industry in...